| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/02/2011 | CN101961387A Traditional Chinese medicine for treating diabetic skin pruritus |
| 02/02/2011 | CN101961386A Traditional Chinese medicine for treating diabetic skin pruritus |
| 02/02/2011 | CN101961385A Chinese medicinal composition tincture for treating hircismus |
| 02/02/2011 | CN101961363A Preparation method of active pseudo-ginseng slices |
| 02/02/2011 | CN101961362A Method for preparing active pseudo-ginseng granule |
| 02/02/2011 | CN101961361A Method for preparing active pseudo-ginseng |
| 02/02/2011 | CN101961350A Preparation method of fishy smell-removed pearl powder |
| 02/02/2011 | CN101961348A Fute panacea |
| 02/02/2011 | CN101961331A Ubiquitin E1 inhibitor and preparation method thereof |
| 02/02/2011 | CN101961308A Methylprednisolone aceponate cream preparation |
| 02/02/2011 | CN101961178A Healthy back cushion |
| 02/02/2011 | CN101596208B Medicine composition for treating burns, scalds, tympanitis and ulceratiue stomatitis |
| 02/02/2011 | CN101559108B Chinese medicinal preparation for treating beriberi, tinea corporis, tinea cruris and method for preparing same |
| 02/02/2011 | CN101502580B External-use medicament for treating tinea manus and pedis |
| 02/02/2011 | CN101474280B Medicament for treating burn and scald, and preparation method thereof |
| 02/02/2011 | CN101396507B Traditional Chinese medicine antibacterial liquid and preparation method and use thereof |
| 02/02/2011 | CN101366911B Traditional Chinese medicine for treating alopecia |
| 02/02/2011 | CN101352495B Medicament for treating anal fistula and preparation method thereof |
| 02/02/2011 | CN101337015B Traditional Chinese medicine for gynecology and dermatology and preparation method thereof |
| 02/02/2011 | CN101326945B Jujube chestnut leaf tea |
| 02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879881 Piperidinyl compounds that selectively bind integrins |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879359 Compositions for preparing external carbon dioxide agents |
| 02/01/2011 | US7879356 AB block polymers, comprising a polylactone part made from monomers such as lactic acid, and B is derived from hydroxyl, amine, or carboxyl terminated compound endcapped with nonreactive group; storage stablity; anti-adhesions |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2490896C Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/01/2011 | CA2483110C Use of a mare milk concentrate dried on a biologically inert, highly disperse matrix |
| 02/01/2011 | CA2482972C The use of hydroxypyridone-derivatives in wound healing |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2470971C Use of pharmaceutical composition containing epidermal growth factor (egf) for preventing diabetic limb amputation |
| 02/01/2011 | CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2442809C Promoter for saccharide uptake |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2406212C Substituted styryl benzylsulfones for treating proliferative disorders |
| 02/01/2011 | CA2403424C Flavone derivatives, preparation method and use as medicines |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 02/01/2011 | CA2274902C Submucosa extracts |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 01/27/2011 | WO2011011506A1 Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| 01/27/2011 | WO2011010732A1 Composition for external preparation for skin |
| 01/27/2011 | WO2011010456A1 EXTERNAL PREPARATION CONTAINING NSAIDs AND METHOD FOR PRODUCING THE EXTERNAL PREPARATION |
| 01/27/2011 | WO2011010306A1 A3 adenosine receptor ligands for modulation of pigmentation |
| 01/27/2011 | WO2011010090A1 Therapeutic uses for plants of the capsicum genus |
| 01/27/2011 | WO2011010075A1 Use of jasmonic acid derivative as a soothing agent |
| 01/27/2011 | WO2010134100A3 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants |
| 01/27/2011 | US20110021772 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021752 Tropoelastin Derivatives |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021632 Use of creatine or creatine compounds for skin preservation |
| 01/27/2011 | US20110021630 Method for treating wounds by administering fullerenes |
| 01/27/2011 | US20110021626 Encapsulation of vitamin c into water soluble dendrimers |
| 01/27/2011 | US20110021619 External preparation for skin containing flavanone derivative |
| 01/27/2011 | US20110021617 Medicinal Acidic Cannabinoids |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021599 Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph |
| 01/27/2011 | US20110021598 Controlled release formulations |
| 01/27/2011 | US20110021582 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 01/27/2011 | US20110021573 Antagonists of prostaglandin d2 receptors |
| 01/27/2011 | US20110021558 Thieno-pyridine derivatives as mek inhibitors |
| 01/27/2011 | US20110021555 Lower dosage strength imiquimod formulations and shorter dosing regimens for treating actinic keratoses |
| 01/27/2011 | US20110021553 Immunosuppressive macrolide powder for oral suspension |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | US20110021545 Novel preparation for external use |
| 01/27/2011 | US20110021530 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021523 Aryl sulfonamides |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021493 Substituted tricyclic compounds and methods of use thereof |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
| 01/27/2011 | US20110021473 Inhibitors of phosphodiesterase type-iv |
| 01/27/2011 | US20110021457 Pharmaceutical compositions comprising modified fucans and methods relating thereto |
| 01/27/2011 | US20110021455 Sterilised sucralfate gel |
| 01/27/2011 | US20110021449 Macrolides and uses of macrolides |
| 01/27/2011 | US20110021447 Acne treatment composition and methods for using |
| 01/27/2011 | US20110021444 Compositions for controlling hair growth |
| 01/27/2011 | US20110021438 Novel compounds of the n-acylamino-amide family, compositions comprising them and uses thereof |
| 01/27/2011 | US20110021431 Methods And Compositions For Medical Articles Produced From Proteinaceous Compounds |
| 01/27/2011 | US20110021428 Prevention of allergy at weaning |
| 01/27/2011 | US20110021422 Method and compositions for prevention and treatment of diabetic and aged skin |
| 01/27/2011 | US20110020476 Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum |
| 01/27/2011 | US20110020468 Silver Oxide Formulations Having Improved Whiteness Characteristics |
| 01/27/2011 | US20110020465 Methods of treatment of gout using thymus-derived compositions |
| 01/27/2011 | US20110020464 Methods of treatment using thymus-derived compositions |
| 01/27/2011 | US20110020457 Polymer-surfactant nanoparticles for sustained release of compounds |
| 01/27/2011 | US20110020437 Oligopeptidic compounds and uses thereof |